| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $160.0M | +3.9% |
| Cost of Revenue | $114.2M | -2.1% |
| Gross Profit | $45.8M | +22.8% |
| R&D Expense | $97.3M | -27.9% |
| SG&A Expense | $141.5M | -19.2% |
| Operating Income | -$553.9M | -16.8% |
| Pre-tax Income | -$546.1M | -76.4% |
| Income Tax | $318K | +0.6% |
| Net Income | -$546.4M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $63.7M | +15.1% |
| Short-term Investments | $215.8M | -35.5% |
| Accounts Receivable | $35.4M | +28.8% |
| Inventory | $49.3M | -16.1% |
| Current Assets | $375.1M | -24.3% |
| Total Assets | $784.1M | -37.8% |
| Current Liabilities | $72.8M | +9.9% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$111.2M | +46.0% |
| Capital Expenditures | $2.7M | -56.1% |
| Investing Cash Flow | $115.4M | -6.9% |
| Financing Cash Flow | $3.4M | +108.0% |
| Free Cash Flow | -$113.9M | +46.3% |
| -76.3% |
| EPS (Basic) | -$1.82 | -61.1% |
| EPS (Diluted) | -$1.82 | -14.5% |
| Total Liabilities |
| $778.7M |
| +3.3% |
| Stockholders' Equity | $5.3M | -98.9% |